MIGLUSTAT DIPHARMA 100 mg, hard capsule capsule
Active ingredients: Miglustat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsulecapsuleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIGLUSTAT DIPHARMA 100 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquettes prédécoupées unitaires polychlortrifluoroéthylène PVC aluminium de 84 x 1 gélules
- Marketing authorisation holder
- DIPHARMA ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62931799CIP73020128CIP133400930201282Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIGLUSTATgélule | 100 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.